Literature DB >> 7619071

Binding of gelatinases A and B to type-I collagen and other matrix components.

J A Allan1, A J Docherty, P J Barker, N S Huskisson, J J Reynolds, G Murphy.   

Abstract

Matrix sequestration of matrix metalloproteinases may be important for the facilitation of remodelling events and the migration of cells through the extracellular matrix. Using an ELISA technique we studied the ability of pro and active forms of gelatinases A and B (GLA and GLB) to bind to matrix components and the contribution made by the different enzyme domains. Pro and active forms of GLA and GLB bound to type-I and type-IV collagens, gelatin and laminin films. Binding to collagens occurred exclusively via the N-terminal portion of the molecule in both of the gelatinases; deletion of the fibronectin-like domain in GLA abolished binding. Fibronectin was shown to compete with GLA, confirming that binding occurs through this domain. GLA and GLB competed for binding to collagen type I, whereas collagenase and stromelysin bound to different sites and could be co-localized with the gelatinases. We conclude that gelatinases have different binding specificities from those previously documented for stromelysin and collagenase, which bind through their C-terminal domains to collagen fibrils.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619071      PMCID: PMC1135833          DOI: 10.1042/bj3090299

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  52 in total

1.  Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells.

Authors:  H Ura; R D Bonfil; R Reich; R Reddel; A Pfeifer; C C Harris; A J Klein-Szanto
Journal:  Cancer Res       Date:  1989-08-15       Impact factor: 12.701

2.  Gelatinases of murine metastatic tumor cells.

Authors:  S Yamagata; R Tanaka; Y Ito; S Shimizu
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

3.  Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase.

Authors:  G Murphy; R Ward; R M Hembry; J J Reynolds; K Kühn; K Tryggvason
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

4.  Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP).

Authors:  R A Williamson; F A Marston; S Angal; P Koklitis; M Panico; H R Morris; A F Carne; B J Smith; T J Harris; R B Freedman
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

5.  Fragments of human fibroblast collagenase. Purification and characterization.

Authors:  I M Clark; T E Cawston
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

6.  SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.

Authors:  S M Wilhelm; I E Collier; B L Marmer; A Z Eisen; G A Grant; G I Goldberg
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

7.  Collagenase is expressed by rabbit VX2 tumour cells in syngeneic and xenogeneic hosts.

Authors:  J Gavrilovic; R M Hembry; J J Reynolds; G Murphy
Journal:  Matrix       Date:  1989-06

8.  Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor.

Authors:  J Martin; M Davies; G Thomas; D H Lovett
Journal:  Kidney Int       Date:  1989-11       Impact factor: 10.612

9.  Genes for extracellular-matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development.

Authors:  C A Brenner; R R Adler; D A Rappolee; R A Pedersen; Z Werb
Journal:  Genes Dev       Date:  1989-06       Impact factor: 11.361

10.  Gelatinase (type IV collagenase) immunolocalization in cells and tissues: use of an antiserum to rabbit bone gelatinase that identifies high and low Mr forms.

Authors:  G Murphy; R M Hembry; A M McGarrity; J J Reynolds; B Henderson
Journal:  J Cell Sci       Date:  1989-03       Impact factor: 5.285

View more
  49 in total

1.  The hairpin structure of the (6)F1(1)F2(2)F2 fragment from human fibronectin enhances gelatin binding.

Authors:  A R Pickford; S P Smith; D Staunton; J Boyd; I D Campbell
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma.

Authors:  B Dahlen; J Shute; P Howarth
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

Review 3.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

4.  Enzymatic processing of collagen IV by MMP-2 (gelatinase A) affects neutrophil migration and it is modulated by extracatalytic domains.

Authors:  Susanna Monaco; Valentina Sparano; Magda Gioia; Diego Sbardella; Donato Di Pierro; Stefano Marini; Massimo Coletta
Journal:  Protein Sci       Date:  2006-11-06       Impact factor: 6.725

Review 5.  Key metalloproteinase-mediated pathways in the kidney.

Authors:  Tammo Ostendorf; Andreas Ludwig; Justyna Wozniak; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2021-04-20       Impact factor: 28.314

6.  A functional polymorphism in THBS2 that affects alternative splicing and MMP binding is associated with lumbar-disc herniation.

Authors:  Yuichiro Hirose; Kazuhiro Chiba; Tatsuki Karasugi; Masahiro Nakajima; Yoshiharu Kawaguchi; Yasuo Mikami; Tatsuya Furuichi; Futoshi Mio; Atsushi Miyake; Takeshi Miyamoto; Kouichi Ozaki; Atsushi Takahashi; Hiroshi Mizuta; Toshikazu Kubo; Tomoatsu Kimura; Toshihiro Tanaka; Yoshiaki Toyama; Shiro Ikegawa
Journal:  Am J Hum Genet       Date:  2008-05-01       Impact factor: 11.025

Review 7.  Extracellular matrix and the kidney.

Authors:  P N Furness
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

8.  Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.

Authors:  Veronica C Ardi; Philippe E Van den Steen; Ghislain Opdenakker; Bernhard Schweighofer; Elena I Deryugina; James P Quigley
Journal:  J Biol Chem       Date:  2009-07-16       Impact factor: 5.157

Review 9.  Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Association of the single nucleotide polymorphisms in the extracellular matrix metalloprotease-9 gene with PACG in southern China.

Authors:  Yanhong Cong; Xiangming Guo; Xing Liu; Dan Cao; Xiaoyun Jia; Xueshan Xiao; Shiqiang Li; Shaohua Fang; Qingjiong Zhang
Journal:  Mol Vis       Date:  2009-07-24       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.